Plain-English translation of NCT06602648 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting melanoma tissue samples from patients under 30 years old to better understand the disease at a molecular level. Researchers will examine the samples using advanced laboratory techniques to identify patterns, genetic changes, and biomarkers that can improve how melanoma is diagnosed and classified in young people.
Melanoma in children, teenagers, and young adults can be difficult to diagnose accurately, and doctors need better tools to understand which tumors are most serious. This study aims to create a shared database and diagnostic platform across Europe that will help standardize melanoma diagnosis and identify new ways to classify the disease based on its biological characteristics.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will use melanoma tissue that was already removed during your treatment or diagnosis. The study does not require new biopsies or procedures — it analyzes existing samples using advanced laboratory techniques including genetic sequencing, imaging, and protein analysis. Your participation helps build a research database that will improve melanoma diagnosis for future young patients across Europe.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Italy